Lineage Cell Therapeutics
Develops off-the-shelf cell-replacement therapies for retinal, spinal-cord, hearing and corneal disease.
$1.11
After-hours close−0.00 (−0.45%)
At close$1.12(−3.88%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 44.80%Insiders —
Shares outstanding 249.30M · Float 236.53M · 94.9% free float
Institutions13F, as of Mar 31, 2026
132 holders · 111.69M shares · 25 new positions · 60 increased · 27 reduced · 17 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Broadwood Capital Inc | 49.56M | 19.88% | 0 | May 15, 2026 |
| Vanguard Capital Management LLC | 8.32M | 3.34% | +8.32Mnew | May 15, 2026 |
| Defender Capital, LLC. | 6.73M | 2.70% | −99.5K | Apr 13, 2026 |
| Millennium Management LLC | 5.56M | 2.23% | +3.45M | May 15, 2026 |
| Raffles Associates LP | 5.36M | 2.15% | 0 | May 15, 2026 |
| Fifth Third Bancorp | 4.60M | 1.85% | +4.60Mnew | May 1, 2026 |
| BlackRock, Inc. | 3.86M | 1.55% | +30.6K | May 13, 2026 |
| Armistice Capital, LLC | 3.18M | 1.28% | +3.18Mnew | May 15, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Neal C. Bradsherincl. Broadwood Partners, L.P., Broadwood Capital, Inc. | 23.10% | 57.85M | 13D | Nov 14, 2025 ↗ |
| BlackRock, Inc. | 5.30% | 13.19M | 13G | Jul 29, 2026 ↗ |
| Chernett Jorey | 5.00% | 11.45M | 13G | Sep 26, 2025 ↗ |
InsidersForm 4
Latest trades
Nothing filed in the last 12 months.
CongressHouse and Senate disclosures
Not reported.